Quarterly report pursuant to Section 13 or 15(d)

Commitments

v3.7.0.1
Commitments
3 Months Ended
Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]  
Commitments
Commitments
 
Lease
The Company has entered into a lease for 14,782 square feet of office and laboratory space located in Austin, Texas. The triple net lease has a term of 48 months and commenced on June 1, 2014. The annual base rent in the first year of the lease was $154,324 and increases by $3,548 in each succeeding year of the lease. In addition, the Company is required to pay its proportionate share of operating costs for the building. The Company has a one-time option to terminate the lease on May 31, 2017 with a termination payment of approximately $99,000. The Company does not plan on exercising this option.
 
At March 31, 2017, the remaining annual base rent commitments, assuming no early termination, under the lease are as follows: 
Year Ended December 31,
 
Amount
2017
 
$
123,134

2018
 
68,736

Total
 
$
191,870


 
The Company incurred rent expense of $57,656 and $55,605 for the three months ended March 31, 2017 and 2016, respectively.
 
License Agreement
 
In 2015, the Company entered into licensing agreements which expire on February 7, 2033. Per the agreements, the Company has an exclusive royalty-free license which enhances its intellectual property portfolio related to semiconductor power switches. The agreements include both fixed and variable payments. The variable payments are a function of the number of associated patent filings pending and patents issued under the agreements. The Company will pay $10,000 for each patent filing pending and $20,000 for each patent issued within 20 days of December 21, 2017 and each subsequent year of the agreement, up to a maximum of $100,000 per year (i.e. five issued patents). At March 31, 2017, one patent associated with the agreements had been issued and the corresponding long-term liability for the estimated present value of future payments under the licensing agreement is $266,938 . The Company is accruing interest for future payments related to the issued patent associated with the agreement.